
|Videos|December 15, 2020
Oral Semaglutide: Cardiovascular Outcomes, Safety, and Tolerability
The safety profile of oral semaglutide across the PIONEER trials was shown to be consistent with other glucagon-like peptide-1 receptor agonists (GLP-1RAs).
Click PLAY to watch the video abstract.
Click
Click
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Latest CME
Trending on AJMC
1
Older Adults Drive Hospitalizations, Costs in the US 2024-2025 Influenza Season
2
RSV Vaccination Effective in Older Adults, but Protection Declines Over Time
3
Discontinuing GLP-1s Before or Early in Pregnancy Tied to Weight Gain, Pregnancy Complications
4
Tapinarof Shows Strong Efficacy, Sleep Benefits in Pediatric AD Across Comorbidities: Druhan Howell, MD
5










































